Search




Results 1-10 of 24.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC1042782017Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-VersagenAUTENRIETH M.; HORN Thomas; KURTZ F; NGUYEN K; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SCHWAIGER M.; BLECHERT B.; SEIDL C.; SENEKOWITSCH-SCHMIDTKE R.; GSCHWEND J.e.; SCHEIDHAUER Klemens
JRC1030832016Dual Isotope Labeled Multimeric PSMA LigandsWURZER A; SEIDL C.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; WESTER Hans-Jürgen; NOTNI Johannes
JRC946682015Pretargeted radioimmunotherapy with Bi-213 in mice with CEA-expressing colon cancer xenograftsHESKAMP Sandra; HERNANDEZ Reinier; ESSLER Markus; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; OYEN Wim; SEIDL C.; MCBRIDE William; GOLDENBERG David; BOERMAN Otto
JRC963852015Alpha- versus beta-emitting particles for pretargeted radioimmunotherapy of CEA-expressing human colon cancer xenograftsHESKAMP Sandra; HERNANDEZ Reinier; MOLKENBOER-KUENEN J.d.m.; ESSLER Markus; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; OYEN Wim; SEIDL C.; MCBRIDE William; GOLDENBERG David; BOERMAN Otto
JRC952242015Fractionated intravesical radioimmunotherapy with 213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinomaFAZEL J; RÖTZER S; SEIDL C.; FEUERECKER Benedikt; AUTENRIETH Michael; WEIRICH G; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.
JRC831802014213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsPICKHARD Anja; PIONTEK Guido; SEIDL C.; KOPPING Samuel; BLECHERT B.; MISSLBECK Martin; BROCKHOFF Gero; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC886722014Step forward with Bi-213: Cyclen-based phosphonates show improved radiolabeling and stabilityŠIMEČEK Jakub; HERMANN Petr; SEIDL C.; MORGENSTERN Alfred; NOTNI Johannes; BRUCHERTSEIFER Frank; WESTER Hans-Jürgen
JRC933312014α-Radioimmunotherapy with 213Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myelomaTEILUF K; SEIDL C.; BLECHERT B.; GAERTNER F. C.; GILBERTZ K.-P.; FERNANDEZ V; BASSERMANN F; ENDELL J; BOXHAMMER R; LECLAIR Stephane; VALLON M.; AICHLER M; FEUCHTINGER A; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC886702014Treatment of bladder cancer with Bi-213-anti-EGFR-MAb – a pilot studySCHEIDHAUER Klemens; SEIDL C.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; AUTENRIETH Michael; KURTZ F; ESSLER M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.
JRC795752013Treatment of Bladder Cancer with Bi-213-anti-EGFR Immunoconjugates in a Nude Mouse ModelSEIDL C.; PFOST B.; MÜLLER Felix; RÖTZER S; FAZEL J; GILBERTZ K.-P.; FEUCHTINGER A; WEIRICH G; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; AUTENRIETH M.; ESSLER M.; SENEKOWITSCH-SCHMIDTKE R.